Schizophrenia Trial, Recruiting NCT07455929 Sponsor: Charite University, Berlin, Germany Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07455929
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a Schizophrenia Spectrum Disorder, confirmed by previous medical records, using standard diagnostic guidelines (ICD-10 or DSM-V)
  • People who are currently receiving psychiatric care as an outpatient (not admitted to hospital)
  • People aged between 18 and 65 years
  • People who are able to understand and agree to participate in the trial (give informed consent)
  • People who are willing and able to take part in group therapy sessions
  • People whose psychotic symptoms are currently low to moderate, as measured by a standard psychiatric rating scale (PANSS) — the trial site will assess this

Who may not be able to join:

  • People with a neurological condition or a history of serious brain injury that may affect thinking or memory
  • People currently dependent on alcohol or non-prescribed drugs (nicotine and prescribed medications are excluded from this rule)
  • People whose psychotic symptoms are rated as very severe on any single item of the PANSS rating scale — the trial site will assess this
  • People who, for any reason, are not suitable for group-based participation (confirm with trial site)
  • People showing signs of acute suicidal thinking, as indicated by a specific score on a standard depression rating scale for schizophrenia — the trial site will assess this
  • People currently receiving certain other treatments at the same time, including electroconvulsive therapy (ECT), ketamine treatment, or intensive psychotherapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4930450517319

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 September 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Proportion of participants receiving threshold dose (Acceptability); Nr. of participants willing to participate in YoGI (Operational Feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov